Mar 18, 2020
Immutep’s Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of Efti
Mar 08, 2020
Immutep Receives Second IND Approval for Efti from US FDA
Feb 18, 2020
Immutep Reports Positive TACTI-002 Data
Feb 04, 2020
Immutep to Present TACTI-002 Interim Data at German Cancer Congress
Jan 29, 2020
Immutep Activities Report
